Top Healthcare Services Acquirers (2007-2026)

Tracked deals

5993

5993 tracked deals across 2007-2026.

Buyer mix

Mixed buyer set

4741 strategic · 3177 pe

Top trend

Volume peaked in 2022

1005 tracked deals announced in 2022.

Primary Insight

What Stands Out

  • Many deals focus on healthcare operations technology: IT spend management (Vizient / Empierus), workforce intelligence for HTM (PartsSource / SkillNet), and analytics for quality reporting (Sagility / CareSeed).
  • Platform expansion appears across subsectors, including pharmacy support for the federal 340B program (Pillr Health / Cooper Strategy) and AI-enabled medical interpretation (AMN Healthcare / Jaide Health).
  • Payer and regulatory analytics are part of the mix, as seen in Sagility’s planned expansion of healthcare quality and Stars capabilities via CareSeed.
  • Geographic activity clusters across North America, with additional agreements in Europe and Israel (including 4DMedical / contextflow in Austria, Healthcare Holding Schweiz AG / Compet Medical AG in Switzerland, and Galmed Pharmaceuticals / Colospan in Israel).

Build a buyer list for your Healthcare Services deal

Find buyers actively acquiring healthcare services companies.

Find buyers like these for your deal

Buyer Snapshot

Top Buyers

Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.

Build a buyer list for your Healthcare Services deal →
Buyer # Deals Focus Type
NMS Capital 63 Private equity firm focused on lower middle market invest... PE
Gryphon Investors 28 Middle-market private equity firm and sponsor; provides c... PE
The Riverside Company 27 Global private equity firm focused on the smaller end of ... PE
Revelstoke Capital Partners 26 Healthcare-focused private equity firm that partners with... PE
Sheridan Capital Partners 23 Chicago-based healthcare private equity firm focused on l... PE
HCAP Partners 22 Southern California-based private equity and mezzanine de... PE
BayMark Health Services 21 Operator of medication-assisted treatment (MAT) and behav... Strategic (PE-backed)
H.I.G. Capital 21 Global alternative investment firm providing equity and d... PE
InTandem Capital Partners 21 Private equity firm focused on investing in and growing h... PE
Linden Capital Partners 21 Healthcare-focused private equity firm investing in middl... PE

Acquisition Volume in Healthcare Services by Year

Last 10 years

Acquisition volume by year Annual acquisition counts for the last 10 years for Top Healthcare Services Acquirers (2007-2026). 28 2017 50 2018 339 2019 599 2020 1002 2021 1005 2022 698 2023 759 2024 838 2025 ~1163 est. 602 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Buyer
    Fiduciary Services Group (FSG)
    Target
    Pension Investors Corporation
    Seller
    Adam Bergman (Owner of Pension Investors)
    Type
    Addon

    Fiduciary Services Group (FSG), the parent company of DWC – The 401(k) Experts, acquired Pension Investors Corporation, a Florida-based third-party administrator (TPA). The deal expands FSG’s retirement plan administration platform and strengthens its footprint in Florida and the Southeast by integrating Pension Investors’ operations into FSG’s TPA business, DWC.

  • Buyer
    Peak Rock Capital (affiliate)
    Target
    Asembia LLC and its related entities (Asembia)
    Seller
    Irene family
    Type
    Buyout

    An affiliate of Peak Rock Capital completed its acquisition of Asembia LLC and its related entities. Asembia provides end-to-end technology-enabled commercialization solutions to the specialty pharma industry, including patient support HUB services, specialty distribution, data services, pharmacy software, and GPO solutions.

  • Buyer
    Trilogy Laboratories
    Target
    YNS Cosmeceuticals
    Type
    Buyout

    Trilogy Laboratories announced the acquisition of YNS Cosmeceuticals, a skincare brand known for its simple daily “Power Trio” system. Trilogy said the deal combines YNS’s skincare philosophy with Trilogy’s pharmaceutical formulation expertise, physician leadership, and FDA-registered manufacturing capabilities to support YNS’s next stage of growth.

  • Buyer
    Parthenon Capital
    Target
    Momentum Life Sciences
    Location
    United States

    Momentum Life Sciences announced a strategic growth investment from Parthenon Capital. Financial terms were not disclosed, and Momentum’s existing leadership team will remain significant shareholders. The investment is intended to accelerate Momentum’s growth and support planned strategic acquisitions across the specialty-therapy commercialization ecosystem.

  • Buyer
    Entity affiliated with consortium led by Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe (WCAS)
    Target
    Select Medical Holdings (Select Medical)
    Type
    Buyout

    Select Medical Holdings announced the completion of its acquisition by an entity affiliated with a consortium led by Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe (WCAS). The transaction values Select Medical at approximately $3.9 billion and was made effective July 1, 2026, with Select Medical’s stock ceasing to trade.

  • Buyer
    Headlands Research
    Target
    Clinical Trials Research (CTR)
    Type
    Buyout

    Headlands Research acquired Clinical Trials Research (CTR), a privately owned clinical research organization with sites in Sacramento and Lincoln, California. The acquired sites will operate as Headlands Research – Sacramento and Headlands Research – CTR Lincoln, expanding Headlands’ California footprint and strengthening its cardiometabolic therapeutic area capabilities. Financial terms were not disclosed.

  • Buyer
    Empower
    Target
    Milliman's retirement administration business
    Seller
    Milliman
    Location
    United States
    Type
    Buyout

    Empower entered into a definitive agreement to acquire Milliman's retirement administration business in a transaction valued at $340 million. The deal is expected to close in the second half of 2026, pending customary regulatory approvals and closing conditions.

  • Buyer
    Experity
    Target
    Exdion Healthcare
    Type
    Addon

    Experity, an on-demand healthcare technology platform for U.S. urgent care clinics, announced it has acquired Exdion Healthcare, an AI-driven chart-to-cash revenue cycle management (RCM) SaaS platform. The acquisition is intended to unify clinical, operational, and financial workflows with AI to accelerate reimbursement, reduce manual work, and improve denials and payment velocity. Exdion’s insurance-focused affiliate is excluded from the transaction and will continue to operate independently.

  • Buyer
    SteriMax Inc.
    Target
    Andone Pharmaceuticals Inc.
    Seller
    Jay Barat (founder; selling party not explicitly stated)
    Location
    Ontario, Canada
    Type
    Buyout

    SteriMax Inc. acquired Andone Pharmaceuticals Inc., a Canadian pharmaceutical and medical device company based in Oakville, Ontario. The deal strengthens SteriMax’s injectable business while expanding its platform into medical device and veterinary markets, with Andone founder Jay Barat joining SteriMax to lead those new businesses.

  • Buyer
    SilverCape Investments
    Target
    PetMed Express
    Type
    Buyout

    SilverCape Investments released an open letter to PetMed Express’s board urging the company to engage with a revised proposal to acquire all outstanding shares for $3.00 per share in cash. The offer represents a ~70% premium to PetMed’s June 26, 2026 closing price and, according to SilverCape, has no financing contingency.

  • Buyer
    AMR Clinical
    Target
    ClinOhio Research Services
    Seller
    Jim Sanders (Founder and Owner of ClinOhio Research Services)
    Type
    Buyout

    AMR Clinical (AMR), an integrated multi-site clinical research company, acquired ClinOhio Research Services, a multi-therapeutic clinical research site based in Columbus, Ohio. The acquisition expands AMR’s geographic presence and strengthens capabilities in Dermatology, Women’s Health, and Gastroenterology.

  • Buyer
    Ipsen
    Target
    Kartos Therapeutics
    Location
    United Kingdom
    Type
    Buyout

    Ipsen entered into a definitive merger agreement to acquire Kartos Therapeutics. The deal will add navtemadlin, a late-stage oral MDM2 inhibitor in Phase III, to Ipsen’s hemato-oncology pipeline.

  • Buyer
    Davion Healthcare Plc
    Target
    Humaskan Ltd
    Location
    Ireland
    Type
    Buyout

    Davion Healthcare Plc has entered into a share purchase agreement to acquire 100% of Humaskan Ltd for total consideration of $60 million, consisting of $10 million in cash and $50 million in Davion shares. The company also plans to establish a wholly owned UK subsidiary, Davion Healthcare Finance Ltd, to support its acquisition program via a proposed corporate bond program of up to £100 million.

  • Buyer
    H.B. Fuller Company (H.B. Fuller)
    Target
    Advanced Medical Solutions Group plc
    Location
    Cheshire, United Kingdom
    Type
    Buyout

    H.B. Fuller (NYSE: FUL) announced a recommended cash offer to acquire Advanced Medical Solutions Group plc (LSE: AMS) for an implied enterprise value of about £715 million. Under the terms, eligible AMS shareholders will receive £2.85 per share in cash, and the deal is expected to close by the end of calendar year subject to approvals and customary conditions.

  • Buyer
    Merakey USA, Boundless
    Target
    Merakey USA

    Boundless and Merakey USA announced a strategic affiliation to create a shared national framework for delivering “whole-person, whole-life care” for people with autism, mental health conditions, substance use disorders, and intellectual/developmental disabilities. Under the affiliation, Boundless will continue operating under its established name while connecting to Merakey’s broader platform and capabilities.

  • Buyer
    Merck KGaA
    Target
    Bio-Techne
    Type
    Buyout

    Merck KGaA entered into a definitive agreement to acquire Bio-Techne for $73 per share in cash, valuing the deal at about $11.3 billion (€9.9 billion). The acquisition is intended to strengthen Merck KGaA’s position across fast-growing life-sciences markets by adding Bio-Techne’s multi-omics, analytical technologies, and integrated workflow solutions.

  • Buyer
    DUOS
    Target
    Linkwell Health
    Type
    Buyout

    DUOS, a “performance infrastructure for health plans,” announced it has acquired Linkwell Health to strengthen its end-to-end platform from enrollment through care completion and health outcomes. The acquisition deepens DUOS’ AI-powered activation layer and expands its footprint to more than 20 health plans nationwide.

  • Buyer
    ChartSpan
    Target
    Validic
    Type
    Buyout

    ChartSpan completed its acquisition of Validic, a personal health data platform focused on wearable and clinical device data integration. The combined company operates as ChartSpan, combining ChartSpan’s care management services with Validic’s remote patient monitoring and health data API/infrastructure to enable continuous patient visibility and proactive clinical action.

  • Buyer
    DermDox Group
    Target
    Modern Aesthetics Plastic Surgery
    Type
    Buyout

    DermDox Group announced the acquisition of Modern Aesthetics Plastic Surgery, an aesthetic medicine and plastic surgery practice serving patients across Pennsylvania. The deal expands DermDox’s integrated dermatology, aesthetic medicine, and plastic surgery capabilities and adds multiple Mid-Atlantic locations under Modern Aesthetics’ name and leadership of Dr. Robert Skalicky.

  • Buyer
    Model N
    Target
    Kalderos
    Type
    Buyout

    Model N announced it has acquired Kalderos, a technology company that provides a gross-to-net intelligence platform for visibility into the 340B drug discount program. The acquisition is intended to expand Model N’s revenue management capabilities and strengthen its 340B offerings for pharmaceutical manufacturers through Kalderos’ Truzo platform.

  • Buyer
    Arthur J. Gallagher & Co.
    Target
    Cincinnati Benefit Solutions, LLC
    Type
    Buyout

    Arthur J. Gallagher & Co. has acquired Cincinnati Benefit Solutions, LLC, an Ohio-based employee benefits services firm focused on small businesses in Cincinnati and nearby areas. Drew Locaputo and the Cincinnati Benefit Solutions team will remain in their current location under the direction of Brian Lomas, head of Gallagher’s Great Lakes region employee benefits consulting and brokerage operations. Financial terms were not disclosed.

  • Buyer
    Integrated Water Services, Inc. (IWS), Sciens Water Opportunities Management, LLC (Sciens Water)
    Target
    Tetrasolv Filtration
    Type
    Buyout

    Integrated Water Services (IWS) acquired Tetrasolv Filtration to expand advanced water treatment, specialized filtration/media services, rentals, and field support capabilities. The deal, which closed on June 22, 2026, positions the combined organization to deliver turnkey wastewater treatment solutions for industrial and municipal mid-market customers.

  • Buyer
    EBI, Avista Healthcare Partners
    Target
    Xstim
    Seller
    Precision Medical Products Inc.
    Location
    United States
    Type
    Addon

    EBI, an Avista Healthcare Partners portfolio company, announced the acquisition of Xstim, a division of Precision Medical Products Inc. Xstim develops a next-generation, wearable, non-invasive spine fusion electrical stimulation therapy intended to support lumbar spinal fusion and related bone-healing applications.

  • Buyer
    Belmont Medical Technologies
    Target
    Arcos, Inc.
    Type
    Addon

    Belmont Medical Technologies acquired Arcos, Inc., a Missouri City, Texas-based health IT company focused on trauma, burn care, and Massive Transfusion Protocol (MTP) workflow software. The acquisition expands Belmont’s life-saving medical technology portfolio by combining Arcos’s Burn Navigator and BloodNav solutions with Belmont’s Rapid Infuser systems.

  • Buyer
    LeadingReach
    Target
    iNaira Healthcare Technologies
    Type
    Buyout

    LeadingReach acquired iNaira Healthcare Technologies to bring EHR integration and automation capabilities in-house. The acquisition supports LeadingReach’s AI-powered “Intelligent Automation Services,” including fax automation, chart creation, and appointment sync that feed structured referrals directly into providers’ EHRs.

  • Buyer
    Slil.com Holding Ltd.
    Target
    I.M.C. Holdings Ltd., Adjupharm GmbH, Xinteza API Ltd., Shiran Societe Anonyme
    Seller
    IM Cannabis Corp.
    Location
    Israel

    IM Cannabis Corp. entered into a non-binding letter of intent to sell its European-focused assets to Slil.com Holding Ltd. The transaction is structured as Slil purchasing IM Cannabis’ wholly owned subsidiary, I.M.C. Holdings Ltd., which will primarily hold the company’s European operations, including Adjupharm GmbH in Germany, and certain API and branded interests.

  • Buyer
    Premier Biotech, Align Capital Partners
    Target
    NexScreen, TransMed
    Seller
    John Debrovner (CEO of NexScreen), Ted Bernhardt (owner of TransMed)
    Type
    Addon

    Align Capital Partners-backed Premier Biotech announced the acquisitions of NexScreen and TransMed to expand its product portfolio, e-commerce capabilities, and global footprint. NexScreen adds point-of-care diagnostic testing presence in Australia and New Zealand, while TransMed strengthens Premier’s catalog and online distribution to 1,000+ direct customer accounts.

  • Buyer
    Altaris, LLC (affiliates)
    Target
    Simulations Plus, Inc., Chemical Computing Group (CCG)
    Type
    Buyout

    Simulations Plus, Inc. has entered into a definitive agreement to be acquired by affiliates of Altaris in an all-cash transaction valued at approximately $375 million. The deal is expected to combine Simulations Plus with Altaris portfolio company Chemical Computing Group (CCG) and is currently expected to close in Q4 2026, subject to customary approvals.

  • Buyer
    Healthcare Revolution Partners
    Target
    Abarca Health, LucyRx
    Location
    Puerto Rico, United States
    Type
    Buyout

    Abarca Health and LucyRx announced a strategic combination to create an independent pharmacy benefit manager (PBM) designed to serve commercial and government clients at scale. The combined company will provide prescription services to more than 9 million members and will operate the Abarca and LucyRx brands as wholly owned subsidiaries of Healthcare Revolution Partners at closing, expected in Q3 2026.

  • Buyer
    Compliancy Group
    Target
    Healthicity
    Type
    Buyout

    Compliancy Group acquired Healthicity, a provider of healthcare compliance and healthcare auditing software, to create a unified platform for healthcare compliance and auditing. The combined organization will serve more than 3,000 healthcare organizations across the U.S. and select global markets, combining workforce compliance, risk assessment, third-party risk, incident management, and provider/coding/documentation auditing capabilities.

  • Buyer
    WPS
    Target
    Mavida Health
    Location
    United States
    Type
    Buyout

    WPS announced its acquisition of Mavida Health, a digital mental health company providing clinical care and community support for women and families across the reproductive journey. The deal expands WPS’s digital healthcare capabilities, with plans to pursue licensure expansion into Wisconsin and evaluate additional member offerings.

  • Buyer
    Thurston Group
    Target
    SGA Dental Partners, Gen4 Dental Partners, Modis Dental Partners
    Type
    Addon

    Thurston Group, a Chicago-based private equity firm, announced the formation of a national dental support platform by uniting SGA Dental Partners, Gen4 Dental Partners, and Modis Dental Partners under the SGA Dental Partners brand. The combined platform will serve 250+ locations and 500+ dentists across 26 states, combining doctor recruiting, professional development, and implant/specialty support capabilities.

  • Buyer
    UpRight Science
    Target
    Highmark's balance assessment application
    Type
    Buyout

    UpRight Science acquired Highmark’s FDA-cleared balance assessment application to bring objective, precise balance measurement into routine clinical care. The technology is intended to help providers measure balance, track changes over time, and intervene before falls occur.

  • Buyer
    Singlepoint Healthcare
    Target
    Healix
    Type
    Buyout

    Singlepoint Healthcare announced its acquisition of Healix, a national provider of outpatient infusion management services based in Sugar Land, Texas. The deal expands Singlepoint’s multi-specialty inflammatory disease care platform by adding Healix’s capabilities across more than 220 physician-owned and ambulatory infusion centers in the U.S.

  • Buyer
    Pelago Bioscience
    Target
    RG Discovery
    Location
    Sweden
    Type
    Buyout

    Pelago Bioscience, a cell-based target engagement contract research organization (CRO), has acquired RG Discovery to create an integrated drug discovery platform spanning biology and medicinal chemistry. The combination is intended to support customers across the full DMTA (design-make-test-analyze) cycle with a single specialist partner, reducing workflow handoffs from hit identification through lead optimization.

  • Buyer
    Consortium of investors (names not disclosed)
    Target
    Gentiva
    Seller
    Humana

    Humana entered into a definitive agreement to divest all or substantially all of its minority interest in Gentiva, an end-of-life care provider. The agreement values Humana’s minority stake at approximately $900 million, with proceeds intended for general corporate purposes; the transaction is expected to close in Q3 2026 subject to approvals.

  • Buyer
    Merck Animal Health
    Target
    TARGAN
    Type
    Buyout

    Merck Animal Health has signed a definitive agreement to acquire TARGAN, a privately held animal-agriculture technology company focused on biodevice solutions for the poultry industry, for an undisclosed amount. The acquisition is expected to close in the third quarter of 2026, subject to regulatory approvals and customary closing conditions.

  • Buyer
    Pillr Health
    Target
    Cooper Strategy
    Type
    Buyout

    Pillr Health announced that it has acquired Cooper Strategy, a Jupiter, Florida-based company that helps covered entities capture savings from the federal 340B drug pricing program. The combined platform will offer expanded pharmacy solutions for hospitals, health systems, and community health centers, including contract pharmacy administration, split billing, compliance support, and pharmacy optimization.

  • Buyer
    PharmaEssentia Corporation
    Target
    FORUS Therapeutics Inc.
    Location
    Canada
    Type
    Buyout

    PharmaEssentia Corporation announced it will acquire 100% of Canadian specialty pharmaceutical company FORUS Therapeutics Inc. in a transaction valued at US$36.5 million. The deal is intended to deepen PharmaEssentia’s presence in Canada’s hematology-oncology myeloproliferative neoplasm (MPN) market and accelerate commercialization of BESREMi (ropeginterferon alfa-2b) by integrating FORUS’s regulatory, medical, and commercial capabilities.

  • Buyer
    Sagility
    Target
    CareSeed
    Type
    Buyout

    Sagility announced it is acquiring CareSeed, a U.S. healthcare analytics company focused on NCQA-certified HEDIS quality reporting and related chart abstraction and regulatory analytics for health plans. The deal is intended to expand Sagility’s AI-led healthcare quality and Stars capabilities and support health plans across the quality lifecycle, moving from retrospective HEDIS reporting toward prospective care gap closure and ongoing performance monitoring.

  • Buyer
    Merrithew International Inc.
    Target
    GYROTONIC organization
    Seller
    Juliu Horvath (founded the GYROTONIC and GYROKINESIS methods)
    Location
    Ontario, Canada
    Type
    Buyout

    Merrithew International Inc. announced the acquisition of the GYROTONIC organization, creator of the GYROTONIC and GYROKINESIS movement methods. The deal is intended to strengthen Merrithew’s global leadership in mindful movement education, training, and equipment by expanding its education and programming portfolio.

  • Buyer
    PartsSource
    Target
    SkillNet
    Type
    Buyout

    PartsSource announced its acquisition of SkillNet, a workforce intelligence platform for healthcare technology management (HTM) that provides hospitals and health systems real-time visibility into technician competencies and team capabilities. The deal expands PartsSource’s Enterprise Clinical Technology platform by adding workforce intelligence to improve clinical capacity and help organizations close technician skill gaps.

  • Buyer
    Med-Metrix, LLC
    Target
    CanAide, Inc.
    Seller
    HCAP Partners
    Type
    Buyout

    Med-Metrix entered into a definitive agreement to acquire CanAide, a provider of Medicaid eligibility and enrollment services and RCM automation solutions. The deal aims to strengthen Med-Metrix’s end-to-end revenue cycle platform by extending front-end capabilities, improving patient access, and enhancing net revenue yield for health system clients.

  • Buyer
    Healthcare Holding Schweiz AG
    Target
    Compet Medical AG
    Seller
    Andreas Baumgartner (CEO and former owner of Compet Medical)
    Location
    Schwyz, Switzerland
    Type
    Buyout

    Healthcare Holding Schweiz AG, a Swiss buy-build-technologize healthcare platform, has acquired Compet Medical AG. Compet Medical, headquartered in Schindellegi (Canton of Schwyz), supplies harm-reduction and hygiene-related products for low-threshold care settings across Switzerland and other European markets.

  • Buyer
    4DMedical
    Target
    contextflow
    Location
    Austria
    Type
    Buyout

    4DMedical announced an agreement to acquire Austrian AI-based software lung imaging company contextflow. The deal is intended to give 4DMedical an immediate commercial and clinical platform in Europe and expand its portfolio of AI-powered respiratory imaging solutions, including lung cancer screening and thoracic imaging.

  • Buyer
    AirCore Environmental, Lewis & Clark Capital
    Target
    Radon Mitigation Services (RMS), Radon Professional Services (RPS)
    Location
    United States
    Type
    Addon

    Lewis & Clark Capital announced the formation of AirCore Environmental, an indoor air quality platform built through the acquisitions of Florida-based Radon Mitigation Services (RMS) and Radon Professional Services (RPS). The platform will initially focus on radon mitigation services for commercial customers across the Southeastern United States and is intended to serve as a foundation for additional complementary IAQ add-ons.

  • Buyer
    AMN Healthcare
    Target
    Jaide Health
    Type
    Buyout

    AMN Healthcare (through its AMN Language Services division) has acquired Jaide Health, an AI-enabled medical interpretation and translation platform. The deal is intended to expand AI-powered language access beyond clinical encounters, supporting patients and care teams across the broader healthcare journey. Financial terms were not disclosed.

  • Buyer
    International SOS Government Medical Services
    Target
    Federal Staffing Resources (FSR)
    Seller
    Epic Staffing Group
    Type
    Buyout

    International SOS Government Medical Services (INTL.SOS GMS) announced the acquisition of Federal Staffing Resources (FSR) from Epic Staffing Group. The deal is intended to expand INTL.SOS GMS’s healthcare staffing capabilities and better support federal, state, and local agencies across the U.S. and overseas.

  • Buyer
    Capsa Healthcare
    Target
    The Harloff Company
    Seller
    The Winsford Company
    Type
    Buyout

    Capsa Healthcare acquired The Harloff Company, a manufacturer of clinical storage cabinets, procedure carts, and medication storage products. The acquisition expands Capsa’s clinical care portfolio and strengthens its ability to deliver integrated, end-to-end solutions across healthcare settings.

  • Buyer
    ECLAT Health Solutions Management (MBO group)
    Target
    ECLAT Health Solutions
    Seller
    Gulf Capital
    Type
    Buyout

    ECLAT Health Solutions, a revenue cycle management, risk adjustment, and healthcare technology provider, completed a management buyout (MBO) from Gulf Capital. The transaction returns full ownership of ECLAT to its founders and management team after a five-year partnership in which the company scaled its workforce from about 450 to over 4,000 employees and grew revenue and EBITDA by roughly 10x.

Full Export

Purchase this data

Get the full acquisitions list for this page as CSV + XLSX.

Build a buyer list for your Healthcare Services deal

Find buyers actively acquiring healthcare services companies.

Apply as a Buyer

Frequently Asked Questions

What types of capabilities are buyers adding in these healthcare services acquisitions?

Common capability themes include healthcare technology management (HTM), IT spend management and cost optimization, workforce intelligence for technician competencies, healthcare analytics for quality reporting, and revenue cycle automation or pharmacy support.

Are these acquisitions limited to one country or region?

No. The recent locations listed include the United States as well as Canada, Israel, Austria, and Switzerland.

Do financial terms appear in every deal announcement?

No. For example, AMN Healthcare’s acquisition of Jaide Health notes that financial terms were not disclosed, while another deal (PharmaEssentia acquiring FORUS Therapeutics) states a transaction value.

What organizations are frequently involved as acquirers in this sector?

Recurring buyer names shown include Serent Capital, KKR, Thurston Group, ARC Health, MBF Healthcare Partners II, L.P., Palm Medical Centers, and Crestline Investors, alongside company acquirers named in the recent events.

Related Acquisition Pages